Pennant EBITDA Margin 2018-2024 | PNTG

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Pennant (PNTG) over the last 10 years. The current EBITDA margin for Pennant as of June 30, 2024 is .
Pennant EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2024-06-30 $0.61B $0.04B 6.37%
2024-03-31 $0.58B $0.04B 6.26%
2023-12-31 $0.54B $0.03B 5.88%
2023-09-30 $0.52B $0.03B 5.93%
2023-06-30 $0.50B $0.03B 6.19%
2023-03-31 $0.49B $0.02B 4.33%
2022-12-31 $0.47B $0.02B 4.02%
2022-09-30 $0.46B $0.01B 2.17%
2022-06-30 $0.45B $0.00B 0.88%
2022-03-31 $0.45B $0.01B 2.46%
2021-12-31 $0.44B $0.01B 2.27%
2021-09-30 $0.44B $0.02B 3.67%
2021-06-30 $0.42B $0.02B 4.50%
2021-03-31 $0.41B $0.02B 5.19%
2020-12-31 $0.39B $0.02B 5.88%
2020-09-30 $0.37B $0.02B 4.84%
2020-06-30 $0.36B $0.02B 4.14%
2020-03-31 $0.35B $0.01B 3.41%
2019-12-31 $0.34B $0.01B 2.96%
2019-06-30 $0.23B $0.01B 5.56%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $1.000B $0.545B
The Pennant Group Inc. through subsidiaries offers home health, hospice and senior living services. It operates primarily in Arizona, California, Colorado, Idaho, Iowa, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin and Wyoming. The Pennant Group Inc. is based in Eagle, United States.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $20.955B 12.68
Quest Diagnostics (DGX) United States $16.785B 17.21
DaVita (DVA) United States $13.482B 16.58
Encompass Health (EHC) United States $9.509B 23.39
Chemed (CHE) United States $8.752B 26.91
Elanco Animal Health (ELAN) United States $7.247B 16.29
RadNet (RDNT) United States $5.079B 120.47
Option Care Health (OPCH) United States $4.985B 24.50
Amedisys (AMED) United States $3.147B 22.51
Astrana Health (ASTH) United States $2.939B 41.59
LifeStance Health (LFST) United States $2.644B 0.00
Addus HomeCare (ADUS) United States $2.286B 27.76
U.S Physical Therapy (USPH) United States $1.222B 33.08
Aveanna Healthcare Holdings (AVAH) United States $0.875B 0.00
Atai Life Sciences (ATAI) Germany $0.195B 0.00
Daxor (DXR) United States $0.042B 0.00
ATI Physical Therapy (ATIP) United States $0.026B 0.00
Psychemedics (PMD) United States $0.013B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.013B 0.00
Ontrak (OTRK) United States $0.006B 0.00
Novo Integrated Sciences (NVOS) United States $0.005B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00